Fig. 1 (abstract O8).
Scatterplot of biosimilar infliximab market shares in the 21 Swedish regions in 2017 and the relative difference in discounted price per defined daily dose (DDD) of the biosimilar relative to the originator product.
Fig. 1 (abstract O8). | Journal of Pharmaceutical Policy and Practice